Skip Navigation
 

An Evening of Wine

 
An Evening of Wine    
An Evening of Wine—First Flight, the first annual fundraiser for Pacific Northwest Research Institute (PNRI, now PNDRI), was an overwhelming success. Over 150 guests arrived at the Golf Club at Newcastle to show their support of PNRI. Attendees experienced an unforgettable evening of Washington State Wines, provided by eight premier Washington wineries. PNRI exceeded its fundraising goal of $100,000 through both the live auction and ticket sales. The audience response to the Fund-A-Need portion of the auction was phenomenal—and as a result $47,200 is earmarked for a one-year training fellowship for a post-doctoral fellow in diabetes research. The event was sponsored by AWineStore.com, Gene Colin, and B & H Investments. Wine partners included Pepper Bridge Winery, Chandler Reach Vineyards, Three Rivers Winery, Saviah Cellars, Sheridan Vineyard, Dunham Cellars, Owen-Sullivan Winery, and Andrew Will Winery.

More

Seattle Biotech Leader Joins National Board
PNRI's Robertson to Help Lead ADA

 
Dr. Paul Robertson    
Dr. R. Paul Robertson, President and Scientific Director of PNRI, has been asked to join the Board of Directors of the American Diabetes Association (ADA). "This is a great opportunity for me, and for PNRI," Robertson says. "It is a chance to represent the academic scientific community in advancing the research and clinical care programs of the ADA. It also underlines PNRI's institutional commitment to grow as a comprehensive diabetes research center." As a new member of the ADA board, Robertson will join two other Seattle diabetes researchers: Steven Kahn, from the VA Puget Sound Health Care System; and Irl Hirsch, from the University of Washington Medical Center. Together, the three represent one of the most important centers of diabetes research in the world.

More

Seeing Cancer Before it Grows and Spreads

 
Dr. Donald Malins    
The September 1, 2004, issue of the Journal of the National Cancer Institute (JNCI) highlights two new papers from the Biochemical Oncology Program at Pacific Northwest Research Institute (PNRI). According to Dr. Donald Malins, lead author of the studies, "early detection is one of the most important tools we have against cancer. To be able to find evidence of a metastasizing tumor before it begins to metastasize would be a very powerful new weapon in the care of cancer patients." Can distinctive changes in DNA structure be seen before cancer tumors begin to grow? Can tumor metastasis be predicted by observing particular DNA alterations in cells? The answer, according to Malins, appears to be yes.

More



720 Broadway - Seattle, WA 98122 - 206.726.1200 - www.pndri.org